In RA, we hypothesized that auto-reactive CD8+ T-cells, particularly those bearing STAT3 mutations, kill target cells such as neutrophils that contain peptidylarginine deiminases (PADs), the enzymes that catalyze citrullination of proteins. The gene discussed is STAT3; the disease is rheumatoid arthritis.